Skip to content
★ Sign in to follow
ME

Magnus Essand

Elicera Therapeutics AB (publ)Elicera Therapeutics AB
Total declarations
8
Companies
2
▲ Purchases (1 ops.)
€5,128
▼ Sales (0 ops.)
—

Latest filing published 23 Jan 2026 for Elicera Therapeutics AB (publ).

Filing timeline

BuySale
Magnus Essand

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Magnus Essand: trading record in brief

Magnus Essand discloses dealings in 2 companies, chiefly Elicera Therapeutics AB and Elicera Therapeutics AB (publ). The record holds 8 filings, for trades running from 10 June 2021 to 22 January 2026.

Purchases make up the whole of the open-market record (1 purchase, €5,128). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants.

The newest entry dates from 23 January 2026: a transaction, in Elicera Therapeutics AB (publ). The most recent open-market purchase was published on 7 July 2021, 1,950 days ago. The median gap between a trade and its publication by Finansinspektionen is 1 day. The legal deadline for notifying a trade is three business days (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Magnus Essand

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total

8 of 8 declarations